Curated dataset · n=51 verified deals · Not live market data · Scores are descriptive, not forecasts.

Network graph, deal flow, valuation matrix, and acquirer landscape.

Apostrophe→Hims & Hers Health

Acquisition · Cash · announced Jun 24, 2021

View in network
  1. Announced

    Jun 24, 2021

  2. Closed

    Jul 7, 2021

Economics

Cash

Up to ~$190M total: ~$150M upfront (~$50M cash plus 8.07M HIMS shares) plus up to $50M earnout on revenue targets (Hims & Hers investor relations, June–July 2021)

Target

Apostrophe

General Wellness · Consumer wellness

HQ San Francisco, CA · Founded 2014

Teledermatology platform with personalized treatment plans and compounding pharmacy; majority female user base

  • Hims & Hers investor relations press release (June 24, 2021)
  • Business Wire - acquisition completion (July 7, 2021)
  • MobiHealthNews coverage (June 2021)

Acquirer

Hims & Hers Health

Healthcare

HQ San Francisco, CA

Multi-specialty telehealth platform for men's and women's health

Why this buyer

Curated copy from the verified dataset — not an 8-K LLM summary

Added teledermatology and compounding pharmacy capability to expand personalized women's skin health offerings

Evidence ladder

Press only — no primary filingValue disclosed
  1. Tertiary (trade / analyst)

    Hims & Hers investor relations (June 24, 2021)

  2. Secondary (press / IR)

    Business Wire (July 7, 2021)

Limitations

  • Citations are press/IR only — two wires of the same announcement are not dual-source. Add a primary filing.
  • Up to ~$190M total: ~$150M upfront (~$50M cash plus 8.07M HIMS shares) plus up to $50M earnout on revenue targets (Hims & Hers investor relations, June–July 2021)

Valuation peers · General Wellness

Same sector, same deal type, announced within ±3 years, disclosed value within 0.25×–4× of this transaction. Ranked by evidence class, then same acquirer.

TargetAcquirerAnnouncedValueWhy included
NurxRoDec 15, 2021same evidence class

Same-sector adjacency — not valuation peers

These deals share the sector tag and window but sit outside the 0.25×–4× value band. The dataset keeps them for clinical adjacency, not as price comps.

TargetAcquirerAnnouncedValueVs this deal
Livongo HealthTeladocAug 5, 2020

Patient empowerment context

Patient empowerment baseline (HLTH 2022)

No curated mapping — Apostrophe (General Wellness). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.

Research workspace (includes heuristic crosswalk) →

Related verified workspaces

Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.

Curated verified dataset v9 · updated 2026-09-20 · 2 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.